Healthcare provider profile · identity verified

Doru A Totoian, MD

Internal Medicine · ROSEBURG, OR · NPI 1457444119

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	464	105
Atorvastatin Calcium	Atorvastatin Calcium	415	103
Amlodipine Besylate	Amlodipine Besylate	326	83
Lisinopril	Lisinopril	303	77
Omeprazole	Omeprazole	298	75
Oxycodone Hcl	Oxycodone Hcl	287	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	283	49
Losartan Potassium	Losartan Potassium	250	65
Gabapentin	Gabapentin	240	55
Duloxetine Hcl	Duloxetine Hcl	216	50
Furosemide	Furosemide	211	50
Potassium Chloride	Potassium Chloride	190	47
Trazodone Hcl	Trazodone Hcl	181	36
Metformin Hcl	Metformin Hcl	176	45
Tizanidine Hcl	Tizanidine Hcl	170	39
Albuterol Sulfate Hfa	Albuterol Sulfate	164	52
Sertraline Hcl	Sertraline Hcl	159	39
Metoprolol Succinate	Metoprolol Succinate	154	43
Carvedilol	Carvedilol	153	43
Metoprolol Tartrate	Metoprolol Tartrate	138	26
Tamsulosin Hcl	Tamsulosin Hcl	138	36
Pantoprazole Sodium	Pantoprazole Sodium	131	32
Alendronate Sodium	Alendronate Sodium	118	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	115	18
Hydrochlorothiazide	Hydrochlorothiazide	113	28
Pregabalin	Pregabalin	108	19
Escitalopram Oxalate	Escitalopram Oxalate	106	19
Clopidogrel	Clopidogrel Bisulfate	102	26
Glipizide	Glipizide	100	27
Xarelto	Rivaroxaban	97	22
Eliquis	Apixaban	90	25
Allopurinol	Allopurinol	89	19
Alprazolam	Alprazolam	86	16
Rosuvastatin Calcium	Rosuvastatin Calcium	83	17
Warfarin Sodium	Warfarin Sodium	83	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	82	19
Lorazepam	Lorazepam	80	18
Pravastatin Sodium	Pravastatin Sodium	80	20
Simvastatin	Simvastatin	78	25
Ozempic	Semaglutide	77	13
Fluticasone Propionate	Fluticasone Propionate	69	18
Tramadol Hcl	Tramadol Hcl	67	11
Celecoxib	Celecoxib	53	16
Clonazepam	Clonazepam	53	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	52	44
Lovastatin	Lovastatin	51	12
Montelukast Sodium	Montelukast Sodium	51	16
Atenolol	Atenolol	48	suppressed
Belsomra	Suvorexant	48	13
Triamcinolone Acetonide	Triamcinolone Acetonide	47	21
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Mirtazapine	Mirtazapine	45	suppressed
Donepezil Hcl	Donepezil Hcl	44	11
Valacyclovir	Valacyclovir Hcl	44	11
Famotidine	Famotidine	43	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	11
Dicyclomine Hcl	Dicyclomine Hcl	42	suppressed
Nebivolol Hcl	Nebivolol Hcl	42	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	42	12
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Morphine Sulfate Er	Morphine Sulfate	38	suppressed
Temazepam	Temazepam	38	suppressed
Clonidine Hcl	Clonidine Hcl	36	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	suppressed
Bupropion Xl	Bupropion Hcl	34	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	34	suppressed
Propranolol Hcl Er	Propranolol Hcl	34	suppressed
Synthroid	Levothyroxine Sodium	34	suppressed
Promethazine Hcl	Promethazine Hcl	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Bumetanide	Bumetanide	30	suppressed
Tradjenta	Linagliptin	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	18
Telmisartan	Telmisartan	29	suppressed
Prednisone	Prednisone	27	suppressed
Primidone	Primidone	27	suppressed
Topiramate	Topiramate	27	suppressed
Ibuprofen	Ibuprofen	26	suppressed
Liothyronine Sodium	Liothyronine Sodium	26	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Nystatin	Nystatin	25	13
Estradiol	Estradiol	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Gemtesa	Vibegron	23	suppressed
Ranolazine Er	Ranolazine	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Torsemide	Torsemide	23	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	22	suppressed
Dutasteride	Dutasteride	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Linzess	Linaclotide	22	suppressed
Oxycontin	Oxycodone Hcl	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Baclofen	Baclofen	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Livalo	Pitavastatin Calcium	19	suppressed
Rexulti	Brexpiprazole	19	suppressed
Finasteride	Finasteride	18	suppressed
Fluconazole	Fluconazole	18	13
Lactulose	Lactulose	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Insulin Aspart Flexpen	Insulin Aspart	17	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	13
Doxepin Hcl	Doxepin Hcl	16	suppressed
Naltrexone Hcl	Naltrexone Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Trintellix	Vortioxetine Hydrobromide	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Novolin N	Insulin Nph Human Isophane	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Valsartan	Valsartan	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Naproxen	Naproxen	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Diazepam	Diazepam	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Multaq	Dronedarone Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error